RPD Stock Analysis: Rapid7 | NASDAQ
Software - Infrastructure | NASDAQ, USA | Market Cap: 1.041m USD | 12M Return: 1.9% | US7534221046 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 27.7M
EPS Trend: -61.9%
Qual. Beats: 3
Rev. Trend: 83.9%
Qual. Beats: 10
Warnings
Tailwinds
Seasonality 11.2 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Rapid7, Inc. (NASDAQ: RPD) is a U.S.-based cybersecurity software and services provider headquartered in Boston, Massachusetts, founded in 2000 and publicly listed since 2015. The company sells its products under the Rapid7, Nexpose, and Metasploit brands, serving customers across on-premises and cloud environments.
Its product portfolio spans vulnerability management, threat detection and response, security information and event management (SIEM), cloud security, application security testing, and attack surface management. Offerings include the Rapid7 Agent for centralized data collection, Network Sensor for traffic analysis, Cloud Event Data Harvesting for cloud visibility, and platforms such as Incident Command (SIEM/XDR), Exposure Command, Surface Command, Vector Command, and Managed Threat Complete. The company also provides managed detection and response, incident response services, threat intelligence, and advisory/professional services.
Rapid7 operates in the Information Technology sector (Systems Software sub-industry), addressing demand for security tools as organizations face rising cyber threats and expanded cloud footprints. Its mix of software platforms and managed services reflects the broader industry shift toward subscription-based and outcome-oriented security offerings.
- Managed Detection and Response revenue accelerates with platform adoption
- Annualized Recurring Revenue growth in Vulnerability Management stabilizes margins
- Federal cybersecurity budget boosts demand for Exposure Command platform
- Pricing pressure intensifies as competition from CrowdStrike and SentinelOne increases
- Customer attrition and deferred revenue trends signal growth deceleration risk
| Net Income: 13.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -2.08 > 1.0 |
| NWC/Revenue: -22.47% < 20% (prev 11.65%; Δ -34.12% < -1%) |
| CFO/TA 0.08 > 3% & CFO 144.5m > Net Income 13.8m |
| Net Debt (293.6m) to EBITDA (59.1m): 4.97 < 3 |
| Current Ratio: 0.83 > 1.5 & < 3 |
| Outstanding Shares: last quarter (70.2m) vs 12m ago 7.66% < -2% |
| Gross Margin: 69.15% > 18% (prev 70.44%; Δ -1.30% > 0.5%) |
| Asset Turnover: 49.99% > 50% (prev 51.53%; Δ -1.54% > 0%) |
| Interest Coverage Ratio: 1.34 > 6 (EBIT TTM 13.7m / Interest Expense TTM 10.2m) |
| A: -0.11 (Total Current Assets 937.9m - Total Current Liabilities 1.13b) / Total Assets 1.74b |
| B: -0.55 (Retained Earnings -953.9m / Total Assets 1.74b) |
| C: 0.01 (EBIT TTM 13.7m / Avg Total Assets 1.70b) |
| D: 0.15 (Book Value of Equity 220.7m / Total Liabilities 1.52b) |
| Altman-Z'' = -2.31 = D |
| DSRI: 0.90 (Receivables 125.4m/141.3m, Revenue 850.4m/858.7m) |
| GMI: 1.02 (GM 70.44% / 69.15%) |
| AQI: 0.74 (AQ_t 0.42 / AQ_t-1 0.57) |
| SGI: 0.99 (Revenue 850.4m / 858.7m) |
| TATA: -0.08 (NI 13.8m - CFO 144.5m) / TA 1.74b) |
| Beneish M = -3.26 (Cap -4..+1) = AA |
As of November 08, 2026, the stock is trading at USD 14.68 with a total of 2,030,340 shares traded. Over the past week, the price has changed by -11.35%, over one month by +19.64%, over three months by +41.43% and over the past year by +1.94%.
Current recommended Stop Loss: 12.50 (which is 14.9% or 1.7 ATR below the current price).
Rapid7 has received a consensus analysts rating of 2.76. Therefore, it is recommended to hold RPD.
- StrongBuy: 1
- Buy: 1
- Hold: 17
- Sell: 3
- StrongSell: 3
| Analysts Target Price | 12.1 | -17.7% |
P/E Trailing = 73.5238
P/E Forward = 8.285
P/S = 1.2238
P/B = 5.1672
P/EG = 0.7817
Revenue TTM = 850.4m USD
EBIT TTM = 13.7m USD
EBITDA TTM = 59.1m USD
Long Term Debt = 892.3m USD (from longTermDebt, last fiscal year)
Short Term Debt = 17.6m USD (from shortTermDebt, last quarter)
Debt = 1.03b USD (from shortLongTermDebtTotal, last quarter) + Leases 67.4m
Net Debt = 293.6m USD (calculated: Debt 1.03b - CCE 731.6m)
Enterprise Value = 1.33b USD (1.04b + Debt 1.03b - CCE 731.6m)
Interest Coverage Ratio = 1.34 (Ebit TTM 13.7m / Interest Expense TTM 10.2m)
EV/FCF = 9.85x (Enterprise Value 1.33b / FCF TTM 135.4m)
FCF Yield = 10.15% (FCF TTM 135.4m / Enterprise Value 1.33b)
FCF Margin = 15.93% (FCF TTM 135.4m / Revenue TTM 850.4m)
Net Margin = 1.63% (Net Income TTM 13.8m / Revenue TTM 850.4m)
Gross Margin = 69.15% ((Revenue TTM 850.4m - Cost of Revenue TTM 262.4m) / Revenue TTM)
Gross Margin QoQ = 69.61% (prev 68.92%)
Tobins Q-Ratio = 0.77 (Enterprise Value 1.33b / Total Assets 1.74b)
Interest Expense / Debt = 0.99% (Interest Expense 10.2m / Debt 1.03b)
Taxrate = 30.75% (6.15m / 20.0m)
NOPAT = 9.48m (EBIT 13.7m * (1 - 30.75%))
Current Ratio = 0.82 (Total Current Assets 937.9m / Total Current Liabilities 1.14b)
Debt / Equity = 4.64 (Debt 1.03b / totalStockholderEquity, last quarter 220.7m)
Debt / EBITDA = 4.97 (Net Debt 293.6m / EBITDA 59.1m)
Debt / FCF = 2.17 (Net Debt 293.6m / FCF TTM 135.4m)
Total Stockholder Equity = 186.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.81% (Net Income 13.8m / Total Assets 1.74b)
RoE = 7.41% (Net Income TTM 13.8m / Total Stockholder Equity 186.7m)
RoCE = 1.27% (EBIT 13.7m / Capital Employed (Equity 186.7m + L.T.Debt 892.3m))
RoIC = 1.63% (NOPAT 9.48m / Invested Capital 582.2m)
WACC = 5.67% (E(1.04b)/V(2.07b) * Re(10.57%) + D(1.03b)/V(2.07b) * Rd(0.99%) * (1-Tc(0.31)))
Discount Rate = 10.57% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 22.34 | Cagr: 5.28%
[DCF] Terminal Value 73.10% ; FCFF base≈147.1m ; Y1≈129.0m ; Y5≈104.2m
[DCF] Fair Price = 20.47 (EV 1.67b - Net Debt 293.6m = Equity 1.38b / Shares 67.4m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -61.94 | EPS CAGR: -13.11% | SUE: 1.90 | # QB: 3
Revenue Correlation: 83.87 | Revenue CAGR: 3.07% | SUE: 2.64 | # QB: 10
EPS current Quarter (2027-03-31): EPS=0.12 | Chg30d=+0.00% | Revisions=+0% | Analysts=4
EPS current Year (2026-12-31): EPS=0.00 | Chg30d=-100.00% | Revisions=+0% | GrowthEPS=-13.5% | GrowthRev=-2.4%
EPS next Year (2027-12-31): EPS=0.51 | Chg30d=-0.30% | Revisions=-25% | GrowthEPS=+5.8% | GrowthRev=-1.2%
[Analyst] Revisions Ratio: -25% (up=0, down=1)